Immediate Impact
58 standout
Citing Papers
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
2023 Standout
Works of Adel Zaatar being referenced
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
2013
Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Adel Zaatar | 324 | 368 | 104 | 124 | 9 | 467 | |
| She-Juan An | 278 | 361 | 136 | 137 | 7 | 447 | |
| Eamon M. Berge | 301 | 418 | 140 | 228 | 14 | 532 | |
| J. M. Sanchez | 291 | 313 | 136 | 206 | 15 | 488 | |
| Maria K. Hristova‐Kazmierski | 255 | 303 | 43 | 101 | 8 | 443 | |
| Jan Nyrop Jakobsen | 188 | 278 | 105 | 146 | 16 | 455 | |
| Alessandro Gamboni | 264 | 359 | 154 | 103 | 12 | 447 | |
| Kim-Son H. Nguyen | 257 | 289 | 105 | 199 | 7 | 419 | |
| D. Chu | 356 | 426 | 108 | 125 | 6 | 502 | |
| Eri Toyoshima | 327 | 233 | 73 | 219 | 15 | 493 | |
| Takashi Nakaoku | 292 | 374 | 187 | 242 | 13 | 562 |
All Works
Loading papers...